Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention

Clinical trial NCT03613337 · UNKNOWN

Trial details

NCT number: NCT03613337
Sponsor: Cui Yimin
Status: UNKNOWN
Study type: OBSERVATIONAL

Smoking Status Genetic Risk Factors Restenosis Clopidogrel Coronary Heart Disease Percutaneous Coronary Intervention

Start date: 2018-05-01
Primary completion: 2020-07-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.